{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T12:34:45Z","timestamp":1774787685149,"version":"3.50.1"},"reference-count":78,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T00:00:00Z","timestamp":1405036800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0102235","type":"journal-article","created":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T18:15:28Z","timestamp":1405102528000},"page":"e102235","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hepatitis C Virus Hypervariable Region 1 Variants Presented on Hepatitis B Virus Capsid-Like Particles Induce Cross-Neutralizing Antibodies"],"prefix":"10.1371","volume":"9","author":[{"given":"Milena","family":"Lange","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothea","family":"Bankwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Osburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei","family":"Viazov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olena","family":"Brovko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel-Rahman","family":"Zekri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yury","family":"Khudyakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Nassal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Pumpens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Pietschmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Timm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Roggendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,7,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2010.00977.x","article-title":"Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses","volume":"239","author":"M Houghton","year":"2011","journal-title":"Immunol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1053\/j.gastro.2010.09.042","article-title":"Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes","volume":"140","author":"AY Kim","year":"2011","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"14199","DOI":"10.1073\/pnas.2335981100","article-title":"In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes","volume":"100","author":"B Bartosch","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"JM Pestka","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1053\/j.gastro.2009.02.080","article-title":"Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus","volume":"136","author":"KA Dowd","year":"2009","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"WO Osburn","year":"2010","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/cis921","article-title":"Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection","volume":"56","author":"K Page","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0140-6736(02)08435-0","article-title":"Protection against persistence of hepatitis C","volume":"359","author":"SH Mehta","year":"2002","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.gastro.2006.12.008","article-title":"Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo","volume":"132","author":"T von Hahn","year":"2007","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/0016-5085(94)90770-6","article-title":"Hypervariable region of hepatitis C virus envelope glycoprotein (E2\/NS1) in an agammaglobulinemic patient","volume":"106","author":"U Kumar","year":"1994","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.510270134","article-title":"Comparison of the rate of sequence variation in the hypervariable region of E2\/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients","volume":"27","author":"JC Booth","year":"1998","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"15331","DOI":"10.1128\/JVI.79.24.15331-15341.2005","article-title":"Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry","volume":"79","author":"N Callens","year":"2005","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1128\/JVI.75.12.5703-5710.2001","article-title":"Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment","volume":"75","author":"F Penin","year":"2001","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1128\/JVI.02200-09","article-title":"Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes","volume":"84","author":"D Bankwitz","year":"2010","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.01594-10","article-title":"Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization","volume":"85","author":"J Prentoe","year":"2011","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1099\/vir.0.028092-0","article-title":"Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein","volume":"92","author":"G Vieyres","year":"2010","journal-title":"J Gen Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1073\/pnas.0832180100","article-title":"Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles","volume":"100","author":"M Hsu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02970149","article-title":"Variability or conservation of hepatitis C virus hypervariable region 1? Implications for immune responses","volume":"28","author":"MU Mondelli","year":"2003","journal-title":"J Biosci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"35631","DOI":"10.1074\/jbc.M112.382341","article-title":"Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion","volume":"287","author":"M Guan","year":"2012","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1006\/viro.1995.1196","article-title":"Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment","volume":"208","author":"A Zibert","year":"1995","journal-title":"Virology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.01592-10","article-title":"Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission","volume":"85","author":"CL Brimacombe","year":"2011","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"15394","DOI":"10.1073\/pnas.93.26.15394","article-title":"Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein","volume":"93","author":"P Farci","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/655902","article-title":"Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins","volume":"202","author":"R Ray","year":"2010","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/08830180109043040","article-title":"Induction of cross-reactive humoral immune response by immunization with mimotopes of the hypervariable region 1 of the hepatitis C virus","volume":"20","author":"R Roccasecca","year":"2001","journal-title":"Int Rev Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0161-5890(01)00084-0","article-title":"Mimotopes of the hyper variable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes","volume":"38","author":"R Roccasecca","year":"2001","journal-title":"Mol Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1053\/jhep.2001.22175","article-title":"Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization","volume":"33","author":"S Zucchelli","year":"2001","journal-title":"Hepatology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/srep00267","article-title":"Hepatitis C virus antigenic convergence","volume":"2","author":"DS Campo","year":"2012","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1126\/science.1123223","article-title":"Viruses: making friends with old foes","volume":"312","author":"T Douglas","year":"2006","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"V Manolova","year":"2008","journal-title":"Eur J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1128\/JVI.77.11.6466-6473.2003","article-title":"Characterization of a conformational epitope on hepatitis B virus core antigen and quasiequivalent variations in antibody binding","volume":"77","author":"JF Conway","year":"2003","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1128\/JVI.64.7.3319-3330.1990","article-title":"Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein","volume":"64","author":"F Birnbaum","year":"1990","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1126\/science.3491425","article-title":"The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen","volume":"234","author":"DR Milich","year":"1986","journal-title":"Science"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"9477","DOI":"10.1073\/pnas.95.16.9477","article-title":"T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles","volume":"95","author":"T Fehr","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/eji.200939559","article-title":"Innate signaling regulates cross-priming at the level of DC licensing and not antigen presentation","volume":"40","author":"SA Keller","year":"2010","journal-title":"Eur J Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.4049\/jimmunol.0803683","article-title":"Interaction of the hepatitis B core antigen and the innate immune system","volume":"182","author":"BO Lee","year":"2009","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000050037","article-title":"HBV core particles as a carrier for B cell\/T cell epitopes","volume":"44","author":"P Pumpens","year":"2001","journal-title":"Intervirology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-3527(08)60808-8","article-title":"Core particles of hepatitis B virus as carrier for foreign epitopes","volume":"50","author":"R Ulrich","year":"1998","journal-title":"Adv Virus Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e1556","DOI":"10.1371\/journal.pone.0001556","article-title":"Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein","volume":"3","author":"AL Gregson","year":"2008","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1128\/IAI.73.6.3587-3597.2005","article-title":"Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial","volume":"73","author":"GA Oliveira","year":"2005","journal-title":"Infect Immun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijmm.2007.08.002","article-title":"Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines","volume":"298","author":"M Nassal","year":"2008","journal-title":"Int J Med Microbiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1073\/pnas.96.5.1915","article-title":"Native display of complete foreign protein domains on the surface of hepatitis B virus capsids","volume":"96","author":"PA Kratz","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"17474","DOI":"10.1074\/jbc.M513571200","article-title":"Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection","volume":"281","author":"C Skamel","year":"2006","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/srep00005","article-title":"SplitCore: An exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure","volume":"1","author":"A Walker","year":"2011","journal-title":"Sci Rep"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1093\/emboj\/17.13.3521","article-title":"Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants","volume":"17","author":"G Puntoriero","year":"1998","journal-title":"EMBO J"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1099\/vir.0.028092-0","article-title":"Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein","volume":"92","author":"G Vieyres","year":"2011","journal-title":"J Gen Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1128\/JVI.71.5.4123-4127.1997","article-title":"Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus","volume":"71","author":"A Zibert","year":"1997","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1073\/pnas.0504877103","article-title":"Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras","volume":"103","author":"T Pietschmann","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/eji.200425449","article-title":"A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula","volume":"35","author":"M Nassal","year":"2005","journal-title":"Eur J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1016\/j.vaccine.2005.02.025","article-title":"A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies","volume":"23","author":"A Geldmacher","year":"2005","journal-title":"Vaccine"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1016\/j.vaccine.2010.07.083","article-title":"Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype","volume":"28","author":"K Ameiss","year":"2010","journal-title":"Vaccine"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000067928","article-title":"A malaria vaccine candidate based on a hepatitis B virus core platform","volume":"45","author":"M Sallberg","year":"2002","journal-title":"Intervirology"},{"key":"ref52","article-title":"SplitCore: An exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure","volume":"1","author":"A Walker","year":"2011","journal-title":"Nature Scientific Reports"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"18249","DOI":"10.1074\/jbc.M211408200","article-title":"Observed hysteresis of virus capsid disassembly is implicit in kinetic models of assembly","volume":"278","author":"S Singh","year":"2003","journal-title":"J Biol Chem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1016\/j.vaccine.2010.02.103","article-title":"Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies","volume":"28","author":"A Jegerlehner","year":"2010","journal-title":"Vaccine"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.vaccine.2006.11.013","article-title":"Advantages to the use of rodent hepadnavirus core proteins as vaccine platforms","volume":"25","author":"JN Billaud","year":"2007","journal-title":"Vaccine"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/285664a0","article-title":"Carrier-priming leads to hapten-specific suppression","volume":"285","author":"LA Herzenberg","year":"1980","journal-title":"Nature"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1586\/erv.09.121","article-title":"Use of hepadnavirus core proteins as vaccine platforms","volume":"8","author":"DC Whitacre","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1128\/JVI.79.21.13656-13666.2005","article-title":"Combinatorial approach to hepadnavirus-like particle vaccine design","volume":"79","author":"JN Billaud","year":"2005","journal-title":"J Virol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrmicro1681","article-title":"The perfect mix: recent progress in adjuvant research","volume":"5","author":"B Guy","year":"2007","journal-title":"Nature Reviews Microbiology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1097-2765(01)80009-5","article-title":"The crystal structure of the human hepatitis B virus capsid","volume":"3","author":"SA Wynne","year":"1999","journal-title":"Mol Cell"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/infdis\/jir511","article-title":"Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus","volume":"204","author":"JC Meunier","year":"2011","journal-title":"J Infect Dis"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1016\/j.vaccine.2003.08.050","article-title":"The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials","volume":"22","author":"S Conaty","year":"2004","journal-title":"Vaccine"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"M Law","year":"2008","journal-title":"Nat Med"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1073\/pnas.0403519101","article-title":"Neutralizing antibody response during acute and chronic hepatitis C virus infection","volume":"101","author":"C Logvinoff","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"e59776","DOI":"10.1371\/journal.pone.0059776","article-title":"A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1\/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans","volume":"8","author":"JL Law","year":"2013","journal-title":"PLoS ONE"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nri891","article-title":"Antibodies, viruses and vaccines","volume":"2","author":"DR Burton","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/infdis\/jit267","article-title":"A heterologous prime\/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus","volume":"208","author":"A Fournillier","year":"2013","journal-title":"J Infect Dis"},{"key":"ref68","first-page":"115ra111","article-title":"Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","author":"E Barnes","journal-title":"Sci Transl Med"},{"key":"ref69","article-title":"Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys","author":"DH Barouch","journal-title":"Nature"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0378-1119(88)90364-2","article-title":"Total chemical synthesis of a gene for hepatitis B virus core protein and its functional characterization","volume":"66","author":"M Nassal","year":"1988","journal-title":"Gene"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/prot.20312","article-title":"Quaternary structure is critical for protein display on capsid-like particles (CLPs): efficient generation of hepatitis B virus CLPs presenting monomeric but not dimeric and tetrameric fluorescent proteins","volume":"58","author":"M Vogel","year":"2005","journal-title":"Proteins"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"33508","DOI":"10.1074\/jbc.M805211200","article-title":"Internal core protein cleavage leaves the hepatitis B virus capsid intact and enhances its capacity for surface display of heterologous whole chain proteins","volume":"283","author":"A Walker","year":"2008","journal-title":"J Biol Chem"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0161-5890(93)90051-C","article-title":"Epitopes recognized by antibodies to denatured core protein of hepatitis B virus","volume":"30","author":"V Bichko","year":"1993","journal-title":"Mol Immunol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jmb.2005.11.053","article-title":"High plasticity of the hepatitis B virus capsid revealed by conformational stress","volume":"356","author":"B Bottcher","year":"2006","journal-title":"J Mol Biol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1006\/viro.1995.1016","article-title":"Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes","volume":"206","author":"RI Connor","year":"1995","journal-title":"Virology"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"41624","DOI":"10.1074\/jbc.M305289200","article-title":"Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor","volume":"278","author":"B Bartosch","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1016\/j.febslet.2005.08.044","article-title":"In vitro assembly of mosaic hepatitis B virus capsid-like particles (CLPs): rescue into CLPs of assembly-deficient core protein fusions and FRET-suited CLPs","volume":"579","author":"M Vogel","year":"2005","journal-title":"FEBS Lett"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1073\/pnas.1834404100","article-title":"Diversity of core antigen epitopes of hepatitis B virus","volume":"100","author":"DM Belnap","year":"2003","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0102235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T06:21:11Z","timestamp":1598077271000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0102235"}},"subtitle":[],"editor":[{"given":"Ranjit","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,11]]},"references-count":78,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0102235","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,11]]}}}